Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias D Hofer

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Urology|December 4, 2020
AUTHOR REPLYMatthias D Hofer
International Journal of Urology : Official Journal of the Japanese Urological Association|December 18, 2013
Editorial comment to Does mechanical bowel preparation ameliorate damage from rectal injury in radical prostatectomy? Analysis of 151 rectal injury casesMatthias D Hofer
Urology|July 27, 2019
EDITORIAL COMMENTMatthias D Hofer
Fundamental & Clinical Pharmacology|September 14, 2018
Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signalMatthias D Hofer
The Journal of Urology|October 7, 2022
Editorial CommentMatthias D Hofer
The Journal of Urology|August 29, 2020
Editorial CommentMatthias D Hofer
The Journal of Urology|March 2, 2019
Editorial CommentMatthias D Hofer
Urology|February 26, 2019
Author ReplyMatthias D Hofer
The Journal of Urology|August 29, 2020
Editorial CommentMatthias D Hofer
The Medical Clinics of North America|February 7, 2018
Urologic EmergenciesAdarsh S Manjunath, Matthias D Hofer
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Urology|December 4, 2020
AUTHOR REPLYMatthias D Hofer
International Journal of Urology : Official Journal of the Japanese Urological Association|December 18, 2013
Editorial comment to Does mechanical bowel preparation ameliorate damage from rectal injury in radical prostatectomy? Analysis of 151 rectal injury casesMatthias D Hofer
Urology|July 27, 2019
EDITORIAL COMMENTMatthias D Hofer
Fundamental & Clinical Pharmacology|September 14, 2018
Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signalMatthias D Hofer
The Journal of Urology|October 7, 2022
Editorial CommentMatthias D Hofer
The Journal of Urology|August 29, 2020
Editorial CommentMatthias D Hofer
The Journal of Urology|March 2, 2019
Editorial CommentMatthias D Hofer
Urology|February 26, 2019
Author ReplyMatthias D Hofer
The Journal of Urology|August 29, 2020
Editorial CommentMatthias D Hofer
The Medical Clinics of North America|February 7, 2018
Urologic EmergenciesAdarsh S Manjunath, Matthias D Hofer
Pageof 11